Regulable gene expression in Gram-positive bacteria
Abstract
A system has been constructed which is suitable for tetracycline-inducible gene expression in Gram-positive bacteria such as Staphylococcus aureus and Bacillus subtilis . The replicon/host gene expression system is tightly regulated, can be used in complex as well as minimal media, and can produce a high level of gene expression upon induction, with a variety of gene products. The gene expression system is suitable for production of products toxic to the host cells, and can be used, for example, for the analysis of gene expression and gene products in Gram-positive bacteria, and in a test of the effect of a peptide or polypeptide inhibitor of an S. aureus enzyme on the growth of S. aureus cells in culture or during infection of an animal.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . Gram-positive bacteria containing one or more tet repressor genes and one or more genes conferring tetracycline resistance.
2 . Bacteria of claim 1 which are staphylococci.
3 . Gram-positive bacteria with a genotype including tetR and tet(M).
4 . Gram-positive bacteria with a chromosomal genotype including tetR and tet(M).
5 . Staphylococcus aureus with a genotype including tetR and one or more genes conferring tetracycline resistance.
6 . Staphylococcus aureus strain CYL316t.
7 . Staphylococcus aureus strain CYL316tt.Join the waitlist — get patent alerts
Track US2003054537A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.